This free survey is powered by QUESTIONPRO.COM
  1. Surveys
  2. 2012
  3. October
  4. P
  5. Post-meeting survey.v02
0%
Exit Survey »
 
 
Welcome!
The objective of this survey is to assess the progress made in achieving the major goals of the Global Pipeline Summit 2012. The survey is designed to capture attendee feedback on specific events and sessions, as well as general input on the Summit.

Your responses are critical to evaluate the conference, and your experiences will inform future Summit planning. Thank you in advance for your participation.
 
 
 
* In your role, what is your area of geographic coverage? (Please select one)
 
Abbott HQ (not exclusively focused on US business)
 
Area – CEE/NWA
 
Area – AAAME
 
Area – WE&C
 
Area – LA
 
Area – Japan
 
Area – U.S.
 
Affiliate (Please specify)
 
 
 
 
* Which of the following best describes your functional area? (Please select one)
 
Market Access / Pricing
 
Government Affairs
 
HEOR
 
Commercial
 
Clinical Development
 
Medical Affairs
 
Regulatory
 
Manufacturing
 
Other (Please specify)
 
 
 
 
* Which of the following therapeutic areas do you cover? (Please select all that apply)
 
Immunology
 
Pain
 
Renal
 
Oncology
 
Virology
 
Neuroscience
 
Women’s Health
 
Other (Please specify)
 

 
 
 
* Which Plenary session(s) did you attend? (Please select all that apply)
 
Opening Plenary
 
Presentation by Rick Gonzalez
 
Closing Plenary
 
I did not attend any Plenary session

 
 
Consider your experience at the Opening Plenary (Wednesday). Please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to begin the summit
* I learned something new and/or important during this session
* The presenters were engaging and motivating
* The length was appropriate
* The format was appropriate
 
 
Consider your experience at the presentation by Rick Gonzalez (Thursday). Please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly agree 2 3 4 = Neutral 5 6 7 = Strongly agree
* It was valuable and important to see the leader of AbbVie at this event
* This session helped put the pipeline in the larger context of the company’s future
* The timing of this session within the overall schedule of events was effective
* The presentation met my expectations
 
 
Consider your experience at the Closing Plenary (Friday). Please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly agree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to end the summit
* The session presented an appropriate forum to answer my questions
* The presenters were engaging and motivating
* The length was appropriate
* The format was appropriate
* I left the summit with a clear view of the next steps
 
 
 
What was the best part of the plenary sessions? Why?
   
 
 
 
What aspect of the plenary sessions would you like to see improved? What suggestions do you have for improvements?
   
 
 
 
* Which Key Compound Breakout sessions did you attend? (Please select all that apply)
 
HCV
 
ABT-719
 
Daclizumab
 
ImmunOP
 
I did not attend any Key Compound Breakout Sessions

 
 
For the HCV Key Compound Breakout, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
For the ABT-719 Key Compound Breakout, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
For the Daclizumab Key Compound Breakout, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
For the ImmunOP Key Compound Breakout, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
 
Please provide additional feedback on any aspect of the Key Compound Breakouts, and list any suggestions you have for improvements.
   
 
 
 
* Which Expert Session did you attend? (Please select all that apply)
 
Immunology
 
ABT-126
 
Oncology
 
Elagolix
 
Humira (Hidradenitis Suppurativa)
 
Humira (Uveitis)
 
I did not attend an Expert Session

 
 
For the Immunology Expert Session, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
For the ABT-126 Expert Session, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
For the Oncology Expert Session, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
For the Elagolix Expert Session, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
For the Humira (Hidradenitis Suppurativa) Expert Session, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
For the Humira (Uveitis) Expert Session, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* There was the right mix of presentation and discussion
* The session addressed high priority issues for my market/asset
* My views were heard and understood
* It was valuable to participate in a discussion with HQ and Area/affiliate colleagues
* I left the session with a clear view on next steps
 
 
 
Please provide additional feedback on any aspect of the Expert Sessions, and list any suggestions you have for improvements.
   
 
 
 
* How much of the pre-reading did you complete in preparation for the Key Compound Breakout and Expert Session discussions? (Please select one)
 
I read all of the pre-reading
 
I read most of the pre-reading
 
I read some of the pre-reading
 
I read none of the pre-reading
 
 
If you completed any of the pre-reading, we are interested in your experience. Please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The pre-reading provided the context I needed to participate fully in the session
* The pre-reading was clear and well written
* The pre-reading was the right length and depth
* The background information in the presentations could have been shorter because the pre-reading effectively covered the information
 
 
 
* If you did not read all of the pre-reading, why were you unable to complete the material? (Please select all that apply)
 
I already had plenty of context on the market and AbbVie’s efforts in the area
 
I did not have time
 
I was not aware pre-reading was available
 
I could not access the pre-reading
 
I did not plan to attend the Key Compound Breakouts or Expert Sessions
 
Other (Please specify)
 

 
 
 
Do you have any suggestions on how to improve the pre-reading material or its use in the presentations? If so, please list them below.
   
 
 
 
* How much of the homework did you complete in preparation for the Key Compound Breakouts and Expert Sessions discussions? (Please select one)
 
I read all of the homework
 
I read most of the homework
 
I read some of the homework
 
I read none of the homework
 
 
If you completed any of the homework, we are interested in your experience. Please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* I knew enough background to complete the questions (from the pre-readings or elsewhere)
* The instructions for the homework were clear and easy to follow
* The number of homework questions that I had to complete was reasonable
* I had sufficient time to complete the homework questions
* I felt my homework submission was reviewed by the product team and constructively incorporated into the discussion
 
 
 
* If you did not complete all of the homework, why were you unable to complete the review of the material? (Select all that apply)
 
I did not have the time
 
I was not aware the homework was available
 
I could not access the homework
 
I did not feel the homework would contribute meaningfully to discussion within the session
 
Other (Please specify)
 

 
 
 
Do you have any suggestions on how to improve the homework material or its use in the presentations? If so, please list them below.
   
 
 
 
* Which Rapid Review Series did you attend? (Please select up to 3 options)
 
ABT-110
 
ABT-981
 
ABT-436
 
ABT-419
 
ADC
 
DVD-Ig
 
Imaging Technologies
 
Corporate Licensing / Acquisitioning & Commercial Business Development
 
Global Alliance Management
 
Global Health Economics and Outcomes Research / Global Value Proposition
 
Governance Review & Launch Playbook
 
Business Intelligence / Insights
 
Finding the Next Generation of Targets
 
Global Forecasting
 
I did not attend a Rapid Review Series

 
 
 
* Why did you choose to attend the specific Rapid Review Series listed? (Please select all that apply)
 
I had more context about what was being presented
 
The topics were more interesting
 
The topics were more relevant for my job
 
The topics were more relevant for my region
 
Other (Please specify)
 

 
If you attended the ABT-110 Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about ABT-110 and pain management
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the novel anti-NGF (nerve growth factor) drug class
* I have a better understanding of ABT-110 (clinical & commercially in both osteoarthritis and chronic low back pain)
 
 
If you attended the ABT-981 Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about ABT-981 and osteoarthritis
* The presenters were engaging and provided the right level of detail
* I have a better understanding of ABT-981, a novel DVD-Ig therapy, and its potential for both disease-modifying activity and symptomatic relief in osteoarthritis
 
 
If you attended the ABT-436 Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about ABT-436 and major depressive disorder (MDD)
* The presenters were engaging and provided the right level of detail
* I have a better understanding of ABT-436
* I have a better understanding of the potential role of biomarkers to enhance the value of ABT-436 in MDD proposition
 
 
If you attended the ABT-419 Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about ABT-419 and schizophrenia
* The presenters were engaging and provided the right level of detail
* I have a better understanding of ABT-419 a potential next-generation compound for negative symptoms of schizophrenia
 
 
If you attended the ADC Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about the ADC platform
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the ADC platform and potential applications in oncology
 
 
If you attended the DVD-Ig Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about the DVD-Ig platform
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the DVD-Ig platform and potential key applications
 
 
If you attended the Imaging Technologies Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about Imaging Technologies
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the Discovery / Early Development organization
* I have a better understanding of how imaging technologies have aided key decisions and de-risked the pipeline
 
 
If you attended the Corporate Licensing / Acquisitions & Commercial Business Development Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about Business Development
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the scientific and commercial assessment process, governance, and key roles and responsibilities
 
 
If you attended the Global Alliance Management Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about Global Alliance Management
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the critical role collaborations play in the LRP sales potential and the key challenges to a successful Alliance and collaboration
* I have a better understanding of the people, process and tools in strategic alliance management
 
 
If you attended the Global Health Economics and Outcomes Research Overview / Global Value Proposition Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about GHEOR and Global Value Proposition
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the critical time windows for GHEOR and Value Proposition research in order to optimize global market access
 
 
If you attended the Governance Review and Launch Playbook Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about Governance Review and the Launch Playbook
* The presenters were engaging and provided the right level of detail
* I have a better understanding of AbbVie's new governance/ decision making process
* I have a better understanding of the key steps to achieving launch excellence
 
 
If you attended the Business Intelligence / Insights Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about Business Intelligence
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the customer journey, and how it is placed into the business context and translated into action
 
 
If you attended the Finding the Next Generation of Targets Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about Discovery / Early Development
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the new Discovery / Early Development organization and its mandate
* I have a better understanding of key areas of biology being explored
 
 
If you attended the Global Forecasting Rapid Review Series, please rate your agreement with the following statements on a scale of 1 to 7.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* The session met my expectations and was an effective way to learn about Global Forecasting
* The presenters were engaging and provided the right level of detail
* I have a better understanding of the organization, mission and methodology of Global Forecasting
 
 
 
Please provide additional feedback on any aspect of the Rapid Review Series, and list any suggestions you have for improvements.
   
 
 
We are interested in your experience at the dinners and networking opportunities. Please rate your agreement with the following statements on a scale of 1 to 7, or select "N/A" for those items where you did not attend or do not have sufficient experience to judge.
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree N/A
* I was able to meet new people and establish contacts that I will draw on in the future
* I was able to reconnect with colleagues who I had not seen in a while
* The structure of the networking opportunities (breakfasts, dinners, etc.) was appropriate
* The number of networking opportunities felt appropriate given the nature of the event
 
 
On a scale of 1 to 7, please rate your experience as a whole along the following dimensions. Please select "N/A" for those items where you did not attend or do not have sufficient experience to judge.
1 = Not positive/Bad experience 2 3 4 = Neutral 5 6 7 = Very positive/ Excellent experience N/A
* Overall impression of the Key Compound Breakouts
* Overall impression of the Expert Sessions
* Overall impression of the Rapid Review Series
* Meeting format/schedule
* Quality of the content
* Communication before and during meetings
* Networking opportunities
* Meeting location
* Meeting facilities
* Meeting logistics (e.g. registration, transportation)
 
 
Based on pre-meeting survey results, participants expected the Global Pipeline Summit to meet three important expectations. On a scale of 1 to 7, how well did the meeting meet these expectations?
1 = Strongly disagree 2 3 4 = Neutral 5 6 7 = Strongly agree
* Helped inform plans for what capabilities will be needed, based on potential upcoming launches
* Provided opportunity to engage in collaborative problem-solving
* Provided deeper understanding of key opportunities and products in AbbVie’s pipeline
 
 
 
* What information did you access on the Global Pipeline Summit website? (Please select all that apply)
 
I never accessed the website
 
Pre-reads and homework questions
 
Meeting agenda
 
Logistics and registration information
 
Contact lists
 
Other (Please specify)
 

 
 
 
What did you like most about the meeting?
   
 
 
 
What changes would you recommend to improve future meetings?
   
 
Survey Software Powered by QuestionPro Survey Software